AI city halls: could Robot-Run domes cure addiction and homelessness?
NCT ID NCT07661823
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will test whether living in a self-contained, AI-managed community (called a Microcity) can improve mental health and reduce addiction in adults with conditions like autism, ADHD, substance use disorders, and behavioral addictions. Up to 1 million participants will live in a dome-enclosed village for up to 24 months, receiving AI-driven counseling, virtual reality therapy, and other digital treatments. The goal is to see if this approach can lower costs and improve outcomes for people on fixed incomes or public assistance.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
AI-managed community with behavioral health services (AI counseling, VR therapy, attitude inoculation protocols)
What this could lead to
If it works, this could point toward a new, low-cost way to deliver mental health and addiction care using AI and self-contained communities.
What could go wrong
This is a very early, non-randomized study with no FDA-regulated drugs or devices. The approach is highly experimental, and results may not apply to broader populations. The massive enrollment goal (1 million) and complex AI system may face practical challenges.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTISM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Administrative Office
Richmond, Virginia, 23219, United States